94 related articles for article (PubMed ID: 16572891)
1. Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study.
Esposito S; Noviello S; Leone S; Ianniello F; Ascione T; Gaeta GB
J Chemother; 2006 Feb; 18(1):33-7. PubMed ID: 16572891
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
Zhang YY; Huang HH; Ren ZY; Zheng HG; Yu YS; Lü XJ; Xiao ZK; Yang HF; Xiu QY; Chen BY; Yue HM; Hao QL; Huang JA; Ma H; Xiao W; Guo DY; Si B; Sun SH; Zhang W; Li QH; Shen HH; Duan J; Li HY; Yao WZ; Gu JM; Xia QM; Ying KJ; Liu A; Yang HP; Shi MH; Sun TY; Ding GH; Wu GM
J Infect Chemother; 2009 Oct; 15(5):301-11. PubMed ID: 19856068
[TBL] [Abstract][Full Text] [Related]
3. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
Peng MY
J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
[TBL] [Abstract][Full Text] [Related]
5. [The clinical efficacy and safety of intravenous levofloxacin in the treatment of 4888 patients with bacterial infections: a multi-center trial].
Cooperation Group for Phase IV Clinical Study of Levofloxacin
Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):492-6. PubMed ID: 19954047
[TBL] [Abstract][Full Text] [Related]
6. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Gisbert JP; Pérez-Aisa A; Bermejo F; Castro-Fernández M; Almela P; Barrio J; Cosme A; Modolell I; Bory F; Fernández-Bermejo M; Rodrigo L; Ortuño J; Sánchez-Pobre P; Khorrami S; Franco A; Tomas A; Guerra I; Lamas E; Ponce J; Calvet X;
J Clin Gastroenterol; 2013 Feb; 47(2):130-5. PubMed ID: 22647827
[TBL] [Abstract][Full Text] [Related]
7. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
Gisbert JP; Bermejo F; Castro-Fernández M; Pérez-Aisa A; Fernández-Bermejo M; Tomas A; Barrio J; Bory F; Almela P; Sánchez-Pobre P; Cosme A; Ortiz V; Niño P; Khorrami S; Benito LM; Carneros JA; Lamas E; Modolell I; Franco A; Ortuño J; Rodrigo L; García-Durán F; O'Callaghan E; Ponce J; Valer MP; Calvet X;
Am J Gastroenterol; 2008 Jan; 103(1):71-6. PubMed ID: 17764498
[TBL] [Abstract][Full Text] [Related]
8. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
Chen Y; Yang H; Lu G; Wu X; Huang W; Wu Y; Lv X; Wu G; Zhang G; Li Q; Sun Y
Chemotherapy; 2012; 58(3):249-56. PubMed ID: 22890091
[TBL] [Abstract][Full Text] [Related]
9. [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Trinchieri A; Marchetti F
Arch Ital Urol Androl; 2003 Mar; 75(1):49-52. PubMed ID: 12741347
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
12. First-line triple therapy with levofloxacin for Helicobacter pylori eradication.
Gisbert JP; Fernández-Bermejo M; Molina-Infante J; Pérez-Gallardo B; Prieto-Bermejo AB; Mateos-Rodríguez JM; Robledo-Andrés P; González-García G
Aliment Pharmacol Ther; 2007 Aug; 26(3):495-500. PubMed ID: 17635384
[TBL] [Abstract][Full Text] [Related]
13. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Gisbert JP; Castro-Fernández M; Bermejo F; Pérez-Aisa A; Ducons J; Fernández-Bermejo M; Bory F; Cosme A; Benito LM; López-Rivas L; Lamas E; Pabón M; Olivares D;
Am J Gastroenterol; 2006 Feb; 101(2):243-7. PubMed ID: 16454825
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of moxifloxacin versus levofloxacin plus metronidazole for community-acquired pneumonia with aspiration factors.
Sun T; Sun L; Wang R; Ren X; Sui DJ; Pu C; Ren Y; Liu Y; Yang Z; Li F
Chin Med J (Engl); 2014; 127(7):1201-5. PubMed ID: 24709166
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of levofloxacin (DR-3355) on uro-genital infections--with special reference to usefulness for chronic prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1992 Jun; 38(6):737-43. PubMed ID: 1632334
[TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin in the treatment of community-acquired pneumonia.
Noreddin AM; Elkhatib WF
Expert Rev Anti Infect Ther; 2010 May; 8(5):505-14. PubMed ID: 20455679
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of peri-operative infection with levofloxacin in female patients undergoing surgery for stress urinary incontinence].
Cao DY; Zhu L; Wang JH; Zhang Y
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1485-7. PubMed ID: 18953856
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience.
Dartois N; Castaing N; Gandjini H; Cooper A;
J Chemother; 2008 Oct; 20 Suppl 1():28-35. PubMed ID: 19036672
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance.
Perna F; Zullo A; Ricci C; Hassan C; Morini S; Vaira D
Dig Liver Dis; 2007 Nov; 39(11):1001-5. PubMed ID: 17889627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
